Results 181 to 190 of about 10,776,501 (260)
Ion Activation Methods for Top‐Down Proteomics
ABSTRACT Mass spectrometry (MS) has emerged as a premier method used to characterize the sequences of proteins. Top‐down proteomics aims to capture the multiple sources of structural diversity reflected in proteins, such as those that arise from alternative RNA splicing events or the addition of post‐translational modifications. Tandem MS (i.e., MS/MS)
Jada N. Walker, Jennifer S. Brodbelt
wiley +1 more source
[Psychoeducation among women with breast cancer and emotional symptoms]. [PDF]
Ortiz-Coronado L +6 more
europepmc +1 more source
Prevention of Early Onset of Breast Cancer With Ashwagandha
ABSTRACT Prevention of breast cancer is feasible because many risk factors for this malignancy are known (e.g., family history, reproductive factors, etc.). Medicinal plants and/or their bioactive phytochemicals are attractive for the prevention of early onset of breast cancer due to their generally favorable safety profile.
Eun‐Ryeong Hahm +2 more
wiley +1 more source
H-score and ERBB2 mRNA refine identification of HER2-low and HER2-ultralow breast cancer. [PDF]
Sartori GP +16 more
europepmc +1 more source
Design of an In Vivo‐Like Phantom for Quantitative Body CEST MRI
ABSTRACT Purpose To design and validate a reproducible in vivo‐like fat‐containing CEST phantom that enables robust quantitative CEST MRI for body applications by providing physiologically realistic relaxation properties, relevant endogenous CEST contrasts (amide, guanidino, rNOE, and semi‐solid MT), and a controlled fat component.
Petr Menshchikov +5 more
wiley +1 more source
Temporal trend and spatial analysis of breast cancer mortality in Paraná, 2012-2021. [PDF]
Santos SGPD +7 more
europepmc +1 more source
ABSTRACT Triple‐negative breast cancer (TNBC) represents the most aggressive subtype with limited therapeutic options and the poorest clinical outcomes. Using high‐resolution nUPLC‐QTOF‐MS/MS, we performed comprehensive proteomic profiling of TNBC cell lines representing disease progression stages: HCC‐1937 (stage IIB), HCC‐1599 (stage IIIA), and MDA ...
Claudia Sissely Chaviano‐Montes de Oca +7 more
wiley +1 more source
Side effects of hormone therapy in patients with malignant breast neoplasm: a cross-sectional study. [PDF]
de Freitas Corpes E +7 more
europepmc +1 more source
High IL6 expression correlates with shorter relapse‐free survival in the basal‐like breast cancer subtype. Nanobacteria‐like particles (NB‐LPs) significantly reduce breast cancer cell viability and IL6 expression levels in MDA‐MB‐231 cells. Abstract Breast cancer is one of the most prevalent malignancies among women worldwide.
Fateme Nikakhtar +2 more
wiley +1 more source
Regionalization and regulation: impact on access to cancer treatment. [PDF]
Duarte LS +6 more
europepmc +1 more source

